UBS Group
ZY

UBS Group’s Zymergen Inc. Common Stock ZY Stock Holding History

UBS Group’s Portfolio ZY Stock Details ZY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-3,800
Closed -$50K – 11164
2021
Q3 		$50K Buy
+3,800
New +$80.6K ﹤0.01% 6338

UBS Group's ZY Position: Q4 2022 in Review

UBS Group sold out of Zymergen Inc. Common Stock (ZY) in Q4 2022, closing a stake of 26,406 shares — an estimated $73K sold.

UBS Group first reported a position in ZY in Q2 2021 and held it in 6 quarters. The position peaked at $1.9M in Q2 2021. 0 funds tracked by Wall St. Rank hold ZY as of Q4 2022.

  • UBS Group reported no remaining Zymergen Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • UBS Group sold 26,406 Zymergen Inc. Common Stock shares in Q4 2022, an estimated $73K.
  • UBS Group first reported a position in Zymergen Inc. Common Stock in Q2 2021 and held it in 6 quarters.
  • UBS Group's Zymergen Inc. Common Stock position peaked at $1.9M in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Zymergen Inc. Common Stock as of Q4 2022.

Based on UBS Group's 13F filing for Q4 2022, filed 8 Feb 2023.